Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients with Eosinophilic Esophagitis - January 22, 2009

Meritage Pharma, Inc. Announces Company Formation and $22.5 Million Series A Financing – June 16, 2008